Russian Registry of Endovascular Closure of Patent Foramen Ovale

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The study will include all patients over 18 years of age who underwent endovascular closure of patent foramen ovale in medical centers in the Russian Federation, who gave written informed consent to the closure and provided personal data as part of inpatient medical care. The project participants will be 29 medical centers in the Russian Federation, where endovascular closure of patent foramen ovale is performed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Patients with an ischemic event (cryptogenic ischemic stroke, transient ischemic attack, embolism of other organs and systems) associated with a PFO;

• Presence of an open oval confirmed by ultrasound diagnostic methods;

• Age of patients from 18 years;

• Life expectancy of at least 1 year;

• Signed informed consent for endovascular closure of a PFO.

Locations
Other Locations
Russian Federation
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
RECRUITING
Moscow
Contact Information
Primary
Andrey Tereschenko
andrew034@yandex.ru
84954150144
Backup
Vadim Yu Kuznetsov
vykuznetsov@cardio.ru
Time Frame
Start Date: 2023-12-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 700
Sponsors
Leads: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

This content was sourced from clinicaltrials.gov